Pragnya Donthineni | Ophthalmology | Innovative Research Award

Innovative Research Award

Pragnya Donthineni
LV Prasad Eye Institute, Hyderabad, India
Pragnya Donthineni
Affiliation LV Prasad Eye Institute, Hyderabad
Country India
Scopus ID 57208902480
Documents 1
Citations 82
h-index 1
Subject Area Ophthalmology
Event Indian Scientist Awards
ORCID 0000-0002-7624-2239

Pragnya Donthineni is an ophthalmology researcher and clinician affiliated with the LV Prasad Eye Institute (LVPEI), Hyderabad, India. Her documented academic work includes research and clinical scholarship in cornea, ocular surface disorders, dry eye disease, cataract-related ocular surface considerations, and related areas of ophthalmic care. Her research record includes publications addressing clinical management, ocular surface disease, corneal disorders, and ophthalmic outcomes, reflecting an interdisciplinary connection between clinical ophthalmology and evidence-based research. [1][2]

Abstract

This academic recognition profile presents the research background and scholarly contributions of Pragnya Donthineni, an ophthalmology professional associated with the LV Prasad Eye Institute in Hyderabad. Her documented research activities encompass corneal and ocular-surface conditions, dry eye disease, cataract-related ocular surface considerations, ocular pain, and other clinically relevant ophthalmic topics. Published work demonstrates engagement with evidence-based clinical investigation, practice guidelines, retrospective clinical analysis, and collaborative ophthalmic research. [1][2][3]

The profile is presented in the context of the Innovative Research Award under the Indian Scientist Awards. The award assessment should be understood as a recognition framework rather than an independent verification of bibliometric indicators. Bibliometric values in the profile are reproduced from the information supplied for this article.

Keywords

Ophthalmology; Innovative Research Award; Pragnya Donthineni; LV Prasad Eye Institute; cornea; ocular surface disease; dry eye disease; cataract surgery; ophthalmic research; clinical research; corneal disorders; evidence-based ophthalmology.

Introduction

Ophthalmology combines clinical medicine, surgical practice, biomedical research, and translational investigation to address diseases affecting vision and ocular function. Within this broad discipline, corneal and ocular-surface research has particular relevance because disorders involving the tear film, cornea, conjunctiva, and associated structures can influence visual quality, comfort, surgical outcomes, and quality of life.

Pragnya Donthineni’s documented academic work is closely associated with the cornea and ocular-surface research environment at LV Prasad Eye Institute. The institutional affiliation is supported by her ORCID record, which identifies employment at LV Prasad Eye Institute in Hyderabad and describes her professional role in cornea and anterior-segment services. [4]

Her published research includes contributions to clinical questions involving dry eye disease, cataract surgery, ocular surface disorders, corneal pathology, and ocular pain. Such areas require integration of clinical observation, diagnostic assessment, treatment considerations, and interpretation of outcomes within established ophthalmic practice. [5]

Research Profile

The supplied research profile identifies Pragnya Donthineni’s primary subject area as Ophthalmology, with institutional affiliation at the LV Prasad Eye Institute in Hyderabad, India. Her ORCID record further identifies a professional appointment at LV Prasad Eye Institute and records a fellowship in cornea and anterior segment services. [4]

The available scholarly record indicates a collaborative research profile, with publications involving clinicians and investigators from LV Prasad Eye Institute and other ophthalmic research institutions. This collaborative model is particularly relevant to translational ophthalmology, where clinical findings, diagnostic approaches, treatment strategies, and outcomes are frequently evaluated across multiple specialties and research settings. [6]

Research Contributions

The documented contributions associated with Pragnya Donthineni span several clinically significant areas of ophthalmology. Her research has included work on dry eye disease, cataract surgery in patients with ocular-surface disease, corneal conditions, ocular surface inflammatory and neoplastic disorders, and ophthalmic pain. [1]

  • Research addressing the diagnosis, clinical approach, and management of aqueous-deficient dry eye disease through evidence-based practice guidance.
  • Investigation of the relationship between dry eye disease and cataract surgery, including visual outcomes and postoperative considerations.
  • Participation in research concerning corneal and ocular-surface disorders, including uncommon and clinically challenging conditions.
  • Contribution to research and scholarly discussion concerning ocular pain and emerging approaches to its pharmacological management.
  • Collaborative research involving clinical ophthalmology, corneal medicine, ocular-surface science, and related translational fields.

These contributions are relevant to contemporary ophthalmic practice because ocular-surface disease can affect patient symptoms, visual function, surgical planning, and postoperative recovery. Research that systematically evaluates these issues can support the development and refinement of clinically informed approaches to patient care. [1] [2]

Publications

The following selected publications are included to document representative areas of Pragnya Donthineni’s research activity. Publication details and DOI information are linked to scholarly records where available.

  1. Donthineni PR, Doctor MB, Shanbhag S, et al. Aqueous-deficient dry eye disease: Preferred practice pattern guidelines on clinical approach, diagnosis, and management. Indian Journal of Ophthalmology. 2023;71(4):1332–1347.
  2. Donthineni PR, Das AV, Shanbhag SS, Basu S. Cataract Surgery in Dry Eye Disease: Visual Outcomes and Complications. Frontiers in Medicine. 2020;7:575834.
  3. Donthineni PR, Munger W, Galor A. Investigating recent advances in pharmacotherapy for acute and chronic ocular pain post-cataract surgery. Expert Opinion on Pharmacotherapy. 2024;25(16):2107–2113.
  4. Sharma S, Donthineni PR, Iyer G, Chodosh J, et al. Keratoprosthesis in dry eye disease. Indian Journal of Ophthalmology. 2023;71(4):1154–1166.
  5. Nibandhe A, Kaliki S, Jakati S, Shanbhag S, Basu S, Donthineni PR. Ocular surface pseudoepitheliomatous hyperplasia secondary to allergic eye disease: clinical features and management. Eye. 2024;38(7):1320–1326.

The publication record demonstrates a research trajectory centered on clinically relevant ophthalmic problems, particularly conditions affecting the cornea and ocular surface. The selected works also illustrate collaborative authorship and multidisciplinary engagement with clinical ophthalmology and related research domains.

Research Impact

Research impact in ophthalmology can be evaluated through several dimensions, including peer-reviewed publications, clinical relevance, citation activity, collaboration, contribution to evidence-based guidance, and the potential applicability of findings to patient care. Pragnya Donthineni’s documented publications address practical clinical questions involving dry eye disease, ocular surface disorders, cataract surgery, corneal conditions, and ocular pain. [1] [2] [3]

The supplied bibliometric profile records 1 document, 82 citations, and an h-index of 1. These figures are included as supplied for the recognition profile and should be interpreted as time-dependent indicators that may vary between databases and over time. Bibliometric measures alone do not establish the quality or significance of individual research contributions.

The existence of peer-reviewed publications addressing clinical practice questions provides an additional dimension to the research profile. For example, published work on dry eye disease has addressed clinical approaches and management recommendations, while other research has examined outcomes and complications associated with cataract surgery in patients with dry eye disease. [1] [2]

Award Suitability

The Innovative Research Award is presented in this article as an academic recognition category associated with the Indian Scientist Awards. Suitability for such recognition may be considered in relation to the relevance, originality, consistency, and potential application of a researcher’s scholarly contributions.

  • Research relevance: The documented work addresses clinically important ophthalmic conditions involving the cornea and ocular surface. [1] [2]
  • Clinical orientation: Several publications focus on questions directly connected with diagnosis, management, surgical outcomes, and patient care. [1] [2] [3]
  • Collaborative scholarship: The publication record includes collaborations with ophthalmologists and researchers across institutions and specialties. [3]
  • Evidence-based contribution: Participation in preferred-practice-pattern guidance demonstrates engagement with the synthesis and interpretation of clinical evidence. [1]
  • Research continuity: The documented works cover multiple related ophthalmic topics, indicating continuing engagement with corneal and ocular-surface research.

On the information available for this profile, the research record provides identifiable evidence of scholarly activity in ophthalmology and clinically oriented research. Final award decisions, however, should remain subject to the official eligibility requirements, documentation review, peer evaluation, and assessment procedures established by the Indian Scientist Awards.

Conclusion

Pragnya Donthineni’s academic profile reflects a focus on ophthalmology, with particular involvement in corneal and ocular-surface research. Her documented publications address dry eye disease, cataract surgery, ocular pain, corneal pathology, and other clinically relevant ophthalmic conditions.

Within the context of the Innovative Research Award, these contributions provide a basis for considering her work as part of an academic recognition process focused on research activity and clinical relevance. The profile should be read together with the underlying scholarly records and the official award evaluation framework.

References

  1. Donthineni PR, Doctor MB, Shanbhag S, et al. Aqueous-deficient dry eye disease: Preferred practice pattern guidelines on clinical approach, diagnosis, and management. Indian Journal of Ophthalmology. 2023;71(4):1332–1347.
    https://doi.org/10.4103/IJO.IJO_2808_22
  2. Donthineni PR, Das AV, Shanbhag SS, Basu S. Cataract Surgery in Dry Eye Disease: Visual Outcomes and Complications. Frontiers in Medicine. 2020;7:575834.
    https://doi.org/10.3389/fmed.2020.575834
  3. Donthineni PR, Munger W, Galor A. Investigating recent advances in pharmacotherapy for acute and chronic ocular pain post-cataract surgery. Expert Opinion on Pharmacotherapy. 2024;25(16):2107–2113.
    https://doi.org/10.1080/14656566.2024.2421323
  4. ORCID. Pragnya Donthineni — ORCID record. Employment and works record associated with LV Prasad Eye Institute.
    https://orcid.org/0000-0002-7624-2239
  5. Sharma S, Donthineni PR, Iyer G, Chodosh J, et al. Keratoprosthesis in dry eye disease. Indian Journal of Ophthalmology. 2023;71(4):1154–1166.
    https://doi.org/10.4103/IJO.IJO_2817_22
  6. Nibandhe A, Kaliki S, Jakati S, Shanbhag S, Basu S, Donthineni PR. Ocular surface pseudoepitheliomatous hyperplasia secondary to allergic eye disease: clinical features and management. Eye. 2024;38(7):1320–1326.
    https://doi.org/10.1038/s41433-023-02897-y
  7. Donthineni PR, et al. Management of cataract in dry eye disease: Preferred practice pattern guidelines. Indian Journal of Ophthalmology. 2023;71(4):1364–1372.
    https://doi.org/10.4103/IJO.IJO_2807_22

 

Mr. Akash Vikal | Nanotechnology and Advanced Materials | Innovative Research Award

Mr. Akash Vikal | Nanotechnology and Advanced Materials | Innovative Research Award

IFTM University, Moradabad, India

Akash Vikal is an emerging pharmaceutical researcher specializing in pharmaceutics, nanomedicine, advanced drug delivery systems, and cancer therapeutics. His academic and research contributions primarily focus on the development of innovative formulation strategies designed to improve therapeutic efficacy, targeted delivery, and patient outcomes. Through extensive research in liposomal formulations, nanocarriers, gene delivery systems, and ocular therapeutics, he has established himself as a promising young contributor to modern pharmaceutical sciences.His research portfolio reflects interdisciplinary expertise integrating pharmaceutical technology, nanotechnology, oncology, ophthalmic therapeutics, and translational medicine. With numerous peer-reviewed publications, book chapters, and scientific presentations, he has actively contributed to advancing pharmaceutical innovation and drug delivery research.

Professional Profile 

Education

Akash Vikal completed a Bachelor of Pharmacy (B.Pharm.) from Shri Gopichand College of Pharmacy with strong academic performance. He further pursued a Master of Pharmacy (M.Pharm.) in Pharmaceutics from ISF College of Pharmacy, where he specialized in advanced pharmaceutical formulation and drug delivery systems. His postgraduate research focused on the “Development and Characterization of Ferulic Acid and Docetaxel Loaded Liposomes Against Breast Cancer” under the guidance of Balak Das Kurmi.

Professional Experience

During his academic journey, Akash Vikal gained industrial exposure through internship training at HIS Pharmaceuticals Pvt. Ltd., where he developed practical knowledge related to pharmaceutical manufacturing and formulation processes. He has also actively contributed to scientific communication and peer-review activities, including reviewing submissions for reputed journals such as Dovepress journals Clinical Ophthalmology and Eye and Brain. In addition, he delivered an academic webinar on scientific writing and publication strategies for researchers and healthcare professionals.

Research Interest

He has contributed extensively to pharmaceutical and biomedical research through numerous publications in reputed international journals. His research covers areas such as metal-organic frameworks in drug delivery, PROTAC-based cancer therapy, nanoparticle-mediated antimicrobial strategies, CRISPR-assisted nanotechnology, nanocarrier systems for ocular therapeutics, and phytoconstituent-based anticancer therapies. Several of his works have been published in recognized journals including Applied Materials Today, Drug Delivery and Translational Research, AAPS PharmSciTech, Current Pharmaceutical Design, and Experimental Eye Research.

Award and Honor

Akash Vikal has received recognition for his academic and scientific contributions through participation in national and international conferences, workshops, and faculty development programs. He earned a Certificate of Excellence in Peer Reviewing for his contribution to academic quality enhancement. His involvement in intellectual property awareness programs, pharmaceutical research conferences, and specialized training workshops reflects his commitment to continuous professional development and scientific advancement.

Conclusion

Mebratu Tafesse Teferi demonstrates strong potential for the Best Researcher Award. His substantial academic qualifications, leadership experience, and dedication to educational research are commendable. His publications reflect significant contributions to Ethiopian education and leadership studies, making him a valuable candidate for the award. To further enhance his candidacy, Mebratu could focus on broadening his research scope, fostering international collaborations, and increasing his publication reach in globally recognized journals.

Publications Top Noted

  • Next-generation gene editing strategies in cancer: Integrating CRISPR, PROTACs, and advanced molecular technologies
    Authors: Akash Vikal, Rashmi Maurya, Pradeep Kumar, Navneet Verma, Arun Kumar Mishra
    Year: 2026
  • Liposomal Paclitaxel in Breast Cancer Therapy: Advances, Clinical Insights, and Future Perspectives
    Authors: Akash Vikal, Rashmi Maurya, Navneet Verma, Arun Kumar Mishra
    Year: 2026
  • A Mini-Review on Unlocking Cognitive Enhancement: An Innovative Strategy for Optimal Brain Functions
    Authors: Akash Vikal, Rashmi Maurya, Brij Bihari Patel, Preeti Patel, Manish Kumar, Balak Das Kurmi
    Year: 2025
  • Andrographis paniculata in Fatty Liver Disease: Mechanisms, Nanocarrier Approaches, and Therapeutic Potential
    Authors: Akash Vikal, Rashmi Maurya, Preeti Patel, Balak Das Kurmi
    Year: 2025
  • Development of Mucopenetrating Pegylated Liposomes Functionalized with Sodium Taurocholate for Enhanced Oral Insulin Delivery
    Authors: Akash Vikal, Rashmi Maurya, Balak Das Kurmi, S. Jindal, R. K. Narang
    Year: 2025
  • From Resistance to Response: Metallic Nanoparticles as Game Changers in Triple Negative Breast Cancer Therapy
    Authors: Akash Vikal, Rashmi Maurya, Preeti Patel, R. K. Narang, Balak Das Kurmi
    Year: 2025
  • Lutein as a Liver Guardian: Insights into its Hepatoprotective Mechanisms, Bioavailability, and Emerging Therapeutic Roles
    Authors: Akash Vikal, Rashmi Maurya, Preeti Patel, Balak Das Kurmi
    Year: 2025
  • Nanoemulsion Technology in Oral Drug Delivery: A Path to Enhanced Solubility and Bioavailability
    Authors: Akash Vikal, Rashmi Maurya, Preeti Patel, Balak Das Kurmi
    Year: 2025
  • Role of dePEGylation in Vesicular Carriers-Mediated Stimuli-Responsive Drug Delivery to Tumors
    Authors: Akash Vikal, Rashmi Maurya, Abhinav Vashishat, Taqdir Singh, Satyam Khare, Preeti Patel, Balak Das Kurmi
    Year: 2025

 

Shivangi Sharma | Applied Chemistry | Best Researcher Award

Ms. Shivangi Sharma | Applied Chemistry | Best Researcher Award

Amity University Gwalior, India

Author Profile

ORCID

GOOGLE SCHOLAR

🎓 EARLY ACADEMIC PURSUITS

Ms. Shivangi Sharma began her academic journey with a Bachelor’s degree in Chemistry, followed by a Master’s degree (M.Sc.) in Chemistry from Jiwaji University, Gwalior, where she earned 3rd rank in her class (2021). Her strong foundational knowledge in chemical sciences laid the groundwork for advanced research. She also completed rigorous summer research training (CSIR-SRTP) focused on advanced materials like carbon nanotubes, showcasing early dedication to applied chemistry and materials science.

🏢 PROFESSIONAL ENDEAVORS

Currently, Ms. Sharma is a Ph.D. Research Scholar at the Department of Applied Chemistry, Amity University Gwalior. Her role involves molecular design, organic synthesis, and biological evaluation of compounds with pharmaceutical potential. She has actively contributed to academic projects, conferences, and collaborative research, gaining experience in both wet-lab synthesis and in silico molecular docking studies.

📚 CONTRIBUTIONS AND RESEARCH FOCUS ON APPLIED CHEMISTRY

Ms. Sharma’s research focuses on:

  • Synthetic Organic Chemistry: Designing and synthesizing heterocyclic compounds such as quinoline and indole derivatives.

  • Biological Evaluation: Testing these compounds for antibacterial and antifungal activities, bridging chemistry and biomedical applications.

  • Molecular Docking: Utilizing computational chemistry tools to predict molecular interactions and guide synthesis.
    Her contributions include more than 28 scientific publications, book chapters, and a dedicated book on organic synthetic methodologies, enhancing the field of applied organic chemistry.

🏅 ACADEMIC CITES, ACCOLADES AND RECOGNITION

  • Over 28 publications in reputed journals and book chapters.

  • An h-index of 2 and 18 citations reflect growing academic influence.

  • 3rd Rank in M.Sc. Chemistry, Jiwaji University, highlighting academic excellence.

  • Presenter at national conferences with recognition for her research contributions.

🌍 IMPACT AND INFLUENCE

Ms. Sharma’s work contributes to the development of novel therapeutic agents that could address antimicrobial resistance, a major global health concern. By integrating synthetic chemistry with biological screening, her research aids pharmaceutical innovation and encourages interdisciplinary approaches in applied chemistry.

🧭 LEGACY AND FUTURE CONTRIBUTIONS

Ms. Sharma aims to:

  • Continue advancing synthetic methodologies for bioactive compounds.

  • Foster collaborations between organic chemistry and pharmacology.

  • Mentor future researchers in applied chemistry.
    Her ongoing projects will likely lead to the development of new drugs, patents, and further scientific publications, strengthening her legacy in applied chemical sciences.

 ✅CONCLUSION

Ms. Shivangi Sharma stands out as a promising researcher in applied synthetic chemistry, blending rigorous academic training with impactful research. Her commitment to solving real-world problems through chemical innovation marks her as a valuable contributor to pharmaceutical chemistry and allied fields.

 🔬NOTABLE PUBLICATION:

Title: Withdrawn: Natural Existence and Bioactivity of Flavonoids: Synthetic Strategies and Mechanistic Pathways
Authors: Shivangi Sharma, Pankaj Kumar Mishra, Shivendra Singh
Journal: Mini-Reviews in Organic Chemistry
Year: 2025



Title: Spider Silk: Biosynthesis, Properties & Bioengineering
Authors: Shivendra Singh, Shivangi Sharma, Snigdha Das, Amlan Kumar Das
Journal: Current Nanomaterials
Year: 2024



Title: Heterocyclic-Based Analogues against Sarcine-Ricin Loop RNA from Escherichia coli: In Silico Molecular Docking Study and Machine Learning Classifiers
Authors: Shivangi Sharma, Rahul Choubey, Manish Gupta, Shivendra Singh
Journal: Medicinal Chemistry
Year: 2024



Title: Conducting Polymer Nanofibers and Nanotubes as a Potential Nanotechnology: Current Status and Future Directions
Authors: Shivangi Sharma, S. Mohanalakhmi
Journal: Current Nanomaterials
Year: 2024



Title: Biochar, Clay, Zeolites, and Microorganism-based Methods for Remediation of Heavy Metals
Authors: Yukti Monga, Shivangi Sharma, Shivendra Singh, Ashu Gupta
Journal: Current Green Chemistry
Year: 2024